Early access: 15,549 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker
H.R. 10476IntroducedHouse · nowSenatePresidentLawIn committee
Sec. 5 · H.R. 10476

Glaucoma and optic nerve damage research

Read this section in the full bill →

This section appears in one version only, so there is nothing to compare yet.

Subpart 9 of part C of title IV of the Public Health Service Act (42 U.S.C. 285i et seq.) is amended by adding at the end the following: 456A. Grants for glaucoma and optic nerve damage research (a) In general The Director of the Institute shall award grants, on a competitive basis, for research related to glaucoma and optic nerve damage, including— (1) optic nerve regeneration and repair; (2) neuroprotection strategies to prevent retinal ganglion cell loss; (3) gene therapies directed at glaucoma-related pathways; and (4) stem cell-based therapies and other advanced approaches to preserving or restoring vision. (b) Authorization of appropriations There is authorized to be appropriated to carry out this section $10,000,000 for the period of fiscal years 2027 through 2028..

Sec. 5: Glaucoma and optic nerve damage research · Public Law Tracker